Ann Doust

No ORCID on file · 12 papers in corpus · active 2012-2025

Study types

  • article 8
  • dataset 2
  • erratum 1
  • other 1

Condition tags

  • endometriosis 8
  • chronic_pelvic_pain 7
  • dysmenorrhea 2
  • dyspareunia 1
article 2025
Dichloroacetate for the treatment of endometriosis-associated pain (EPiC1): a single-arm feasibility study
·doi:10.1016/j.lanogw.2025.100028
article 2024
Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain
·doi:10.3389/fphar.2024.1460206

Introduction Chronic pelvic pain affects up to 24% of women worldwide and for up to 55% of these there is no associated pathology. Despite this there are no established treatments in this cohort. This is a secondary analysis of a randomised…

article 2023
Effectiveness of laparoscopic removal of isolated superficial peritoneal endometriosis for the management of chronic pelvic pain in women (ESPriT2): protocol for a multi-centre randomised controlled trial
Trials ·doi:10.1186/s13063-023-07386-x

BACKGROUND: Endometriosis affects 190 million women and those assigned female at birth worldwide. For some, it is associated with debilitating chronic pelvic pain. Diagnosis of endometriosis is often achieved through diagnostic laparoscopy.…

dataset 2021
ESPriT2 – a multicentre clinical trial to determine whether surgical removal of superficial peritoneal endometriosis improves pain symptoms and quality of life
·doi:10.1186/isrctn27244948
other 2021
Laparoscopic treatment of isolated superficial peritoneal endometriosis for managing chronic pelvic pain in women: study protocol for a randomised controlled feasibility trial (ESPriT1)
Pilot and feasibility studies ·doi:10.1186/s40814-020-00740-9

BACKGROUND: Endometriosis (where endometrial-like tissue is found outside the uterus) affects ~ 176 million women worldwide and can lead to debilitating pelvic pain. Three subtypes of endometriosis exist, with ~ 80% of women having superfic…

article 2020
A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1)
PloS one ·doi:10.1371/journal.pone.0227695

BACKGROUND: Endometriosis is defined by the presence of endometrial-like tissue (lesions) outside the uterus, commonly on the pelvic peritoneum. It affects 6-10% of women and is associated with debilitating pelvic pain. Current management o…

erratum 2020
Correction: A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1)
PloS one ·doi:10.1371/journal.pone.0230055

[This corrects the article DOI: 10.1371/journal.pone.0227695.].

article 2020
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial
·doi:10.1016/s0140-6736(20)31693-7

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…

article 2020
Randomised controlled trial of gabapentin for chronic pelvic pain in women

Background Chronic pelvic pain (CPP) affects 2-24% of women worldwide and evidence for medical treatments is limited. Gabapentin is effective in treating some chronic pain conditions. We aimed to determine the efficacy and safety of gabapen…

article 2018
A pilot randomised double blind controlled trial of the efficacy of purified fatty acids for the treatment of women with endometriosis-associated pain (PurFECT): study protocol
Pilot and feasibility studies ·doi:10.1186/s40814-018-0274-8

BACKGROUND: Endometriosis affects 6-10% of women and is associated with debilitating pelvic pain. It costs the UK > £2.8 billion per year in loss of productivity. Endometriosis can be managed by surgical excision or medically by ovarian sup…

dataset 2017
Purified fatty acids for endometriosis clinical trial
·doi:10.1186/isrctn44202346
article 2012
GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol: Figure 1
·doi:10.1136/bmjopen-2012-001297

INTRODUCTION: Chronic pelvic pain (CPP) affects >1 million UK women. Annual healthcare costs are estimated at >£150 million. Proven interventions for CPP are limited, and treatment is often unsatisfactory. Gabapentin is increasingly prescri…